Forest sues Lupin to protect $1.5bn Namenda

19-08-2014

Forest sues Lupin to protect $1.5bn Namenda

Lightspring / Shutterstock.com

Actavis-owned pharmaceutical company Forest, along with US-based Adamas Pharmaceuticals, has sued Indian generic drug maker Lupin for infringing seven patents directed to its Alzheimer’s drug Namenda XR (memantine hydrochloride), a once daily version of Namenda.


Forest, Lupin, Namenda, patent infringement, ANDA

LSIPR